Richard Schulick, MD, MBA, FACS
Disclosures: Royalty-Co-Inventor of Patent-Aduro Biotech-coinventor of a patent that uses genetically modified Listeria to treat cancer. It is licensed to Aduro Biotech. This is managed by Johns Hopkins University|Consulting to which seeks expert consults for patients who contact them. This is managed by the University of Colorado|Royalty-GlaxoSmithKline-Other_Role-coinvertor of patent that uses CD112 pathway to alter immune response. Managed by University of Colorado|On Board of NOILE Immune. Not compensated-Other_Role - 08/26/2021
No Bio Available.